
Pagmet OD 1500mcg/150mg Tablet SR
Marketer
Cubit Healthcare
Salt Composition
Methylcobalamin (1500mcg) + Pregabalin (150mg)
Overview Pagmet OD 1500mcg/150mg Tablet SR
Neuropathic pain is treated with the prescription medication Pagmet OD 1500mcg/150mg Tablet SR, a sustained-release tablet. Its mechanism involves modulating nerve cell calcium channel activity to reduce pain, while also safeguarding and repairing nerve fibers. Administered orally, Pagmet OD can be taken with or without food, ideally before sleep, consistently at the same time daily for optimal blood levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, regardless of symptom improvement. Abrupt cessation should be avoided without prior consultation. Common, generally mild, side effects may include nasal congestion, increased hunger, elevated mood, shaking, visual blurring, dry mouth, lightheadedness, and drowsiness, typically improving over time. Avoid activities requiring concentration until the medication's effects are understood. Weight gain is possible; regular exercise and a balanced diet can help manage this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal thoughts to your doctor immediately. Disclose all other medications you are using, as interactions can impact Pagmet OD's efficacy or action. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Uses of Pagmet OD 1500mcg/150mg Tablet SR
Managing neuropathic pain
Major Benefits of Pagmet OD 1500mcg/150mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pagmet OD 1500mcg/150mg Sustained-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Pagmet OD 1500mcg/150mg Tablet SR:
- Sleepiness
- Dizziness
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Increased appetite
- Blurred vision
- Constipation
- Muscle cramp
- Edema (swelling)
- Erectile dysfunction
- Weight gain
- Balance disorder (loss of balance)
- Lethargy
- Vertigo
- Vomiting
- Headache
- Confusion
- Disorientation
- Abnormality of voluntary movements
How to use Pagmet OD 1500mcg/150mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Pagmet OD 1500mcg/150mg Sustained-Release tablet can be consumed with or without food, though consistent timing is recommended.
How Pagmet OD 1500mcg/150mg Tablet SR works:
Combining methylcobalamin (a vitamin B12 variant) and pregabalin, Pagmet OD 1500mcg/150mg SR tablets offer dual-action neuropathic pain relief. Methylcobalamin supports myelin sheath production, shielding nerve fibers and aiding damaged nerve cell recovery. Pregabalin, an alpha-2-delta ligand, reduces pain by regulating nerve cell calcium channel function. This synergistic effect targets and alleviates pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Pagmet OD 1500mcg/150mg sustained-release tablets and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Pagmet OD 1500mcg/150mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Pagmet OD 1500mcg/150mg tablet is likely unsafe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Pagmet OD 1500mcg/150mg SR tablets might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Pagmet OD 1500mcg/150mg sustained-release tablets cautiously. Dosage modification of Pagmet OD 1500mcg/150mg sustained-release tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Pagmet OD 1500mcg/150mg SR tablets in patients with liver impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Pagmet OD 1500mcg/150mg Tablet SR :
Should you forget a Pagmet OD 1500mcg/150mg Tablet SR dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Pagmet OD 1500mcg/150mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
